Novo Nordisk A/S: Delårsrapport for perioden 1. januar til 30. september 2011
| Source: Novo Nordisk A/S
Recommended Reading
-
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 16 November 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No...
Read More -
FREHEMGO® (denecimig) approved in the EU for haemophilia A, with a choice of monthly, every-two-weeks or weekly dosing
Read More